No Data
No Data
Hong Kong stock Concept tracking | Seven departments issued a document to promote the digital transformation of the pharmaceutical industry. AI pharmaceutical manufacturing shows great potential (including concept stocks).
The National Health Commission and six other departments jointly issued the "Implementation Plan for the Digital Transformation of the Pharmaceutical Industry (2025-2030)."
Sinolink Securities initiates coverage of Yidu Technology (02158) with a Buy rating and a Target Price of 7 Hong Kong dollars.
Sinolink recently released a research report on Yidu Technology (02158) for its first coverage, highlighting its core advantages and growth potential in the AI Medical field. Based on the accelerated promotion of its AI platform products and industry-leading data governance capabilities, a "Buy" rating is given with a Target Price of 7 Hong Kong dollars.
Trending Industry Today: ALI HEALTH Leads Gains In AI Medical Concept Stocks
Trending Industry Today: MEDBOT-B Leads Gains In AI Medical Concept Stocks
Trending Industry Today: MOBVISTA Leads Losses In ByteDance Ecosystem Stocks
Trending Industry Today: XTALPI-P Leads Losses In AI Medical Concept Stocks